Uecker Darrin's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Sep 15, 2025
- Accession no.
- 0001437749-25-029104
- Filed
- Sep 15, 2025
- Trade date
- Sep 11-15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.12M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Uecker DarrinCIK 0001276311 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | MOption exerciseAcquired | +25,000 | $4.00 | +$100,000 | 147,872 | Direct | |
| Sep 11, 2025 | Common Stock | SSaleDisposed | −25,000 | $14.78F2 | −$369,500 | 122,872 | Direct | |
| Sep 12, 2025 | Common Stock | MOption exerciseAcquired | +25,000 | $4.00 | +$100,000 | 147,872 | Direct | |
| Sep 12, 2025 | Common Stock | SSaleDisposed | −25,000 | $14.32F3 | −$358,000 | 122,872 | Direct | |
| Sep 15, 2025 | Common Stock | MOption exerciseAcquired | +25,000 | $4.00 | +$100,000 | 147,872 | Direct | |
| Sep 15, 2025 | Common Stock | SSaleDisposed | −25,000 | $15.77F4 | −$394,250 | 122,872 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 156,534 | Direct | |
| Sep 12, 2025 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 131,534 | Direct | |
| Sep 15, 2025 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 106,534 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share.
Referenced by the price of 1 transaction in Table I.
- F4
The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share.
Referenced by the price of 1 transaction in Table I.